Estimated impact and cost-effectiveness of rotavirus vaccination in India: Effects of geographic and economic disparities

Vaccine

Volumn 32, Issue S1, 2014, Pages

  Rheingans, Richard ^a   Anderson, John D ^a   Anderson, Benjamin ^a   Chakraborty, Poulomy ^a   Atherly, Deborah ^b   Pindolia, Deepa ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b PATH   (United States)

Author keywords

Cost effectiveness; Disparities; Equity; India; Rotavirus; Vaccination

Indexed keywords

ROTAVIRUS VACCINE;

COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; EPIDEMIOLOGY; GEOGRAPHY; HEALTH CARE COST; HEALTH DISPARITY; HUMAN; INDIA; INFANT; MORTALITY; PRESCHOOL CHILD; ROTAVIRUS INFECTIONS; SOCIOECONOMICS; STATISTICAL MODEL; VACCINATION;

CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; GEOGRAPHY; HEALTH CARE COSTS; HEALTH STATUS DISPARITIES; HUMANS; INDIA; INFANT; MODELS, ECONOMIC; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOCIOECONOMIC FACTORS; VACCINATION;

EID: 84905167324     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.05.073     Document Type: Article

References (47)

1. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(9730):1969-1987.
2. Parashar U.D., Gibson C.J., Bresee J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12:304-306.
3. WHO Rotavirus vaccines:an update. Wkly Epidemiol Rec 2009, 84(50):533-540.
4. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(Suppl. 1(Nov)):S9-S15.
5. Esposito D.H., Tate J.E., Kang G., Parashar U.D. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008. Clin Infect Dis 2010, 52(2):171-177.
6. Neogi S.B., Hasan H., Sheikh K., Zodpey S. Scope for rotavirus vaccination in India: revisiting the scientific evidence. Ind J Pediatr 2011, 78(10):1251-1255.
7. Rheingans R., Atherly D., Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine 2012, 30(Suppl. 1):A15-A23.
8. Atherly D.E., Lewis K.D.C., Tate J., Parashar U.D., Rheingans R.D. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine 2012, 30:A7-A14.
9. Rose J., Hawthorn R.L., Watts B., Singer M.E. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ (Clin Res ed) 2009, 339(25(Sep)):b3653-b3660.
10. Bhandari N., Rongsen-Chandola T., Bavdekar A., John J., Antony K., Taneja S., et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014, (9935(Jun 21)):2136-2143.
11. Indian Academy of Pediatrics Committee on Immunization (IAPCOI) Consensus recommendations on immunization and IAP immunization timetable 2012. Ind Pediatr 2012, 49(7):549-564.
12. Lodha R., Shah D. Prevention of rotavirus diarrhea in India: is vaccination the only strategy?. Ind Pediatr 2012, 49(6):441-443.
13. Bányai K., László B., Duque J., Steele A.D., Nelson E. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012, 30(Suppl 1):A122-A130.
14. Morris S., Awasthi S., Khera A., Bassani D., Kang G., Parashar U., et al. Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths. Bull World Health Organ 2012, 90(10):720-727.
15. Caulfield L., de Onis M., Blossner M., Black R. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr 2004, 80(1):193-198.
16. Nandy S., Irving M., Gordon D., Subramanian S.V., Smith G.D. Poverty, child undernutrition and morbidity: new evidence from India. Bull World Health Organ 2005, 83(3):210-216.
17. Gaudin S., Yazbeck A.S. Immunization in india 1993-1999: wealth, gender, and regional inequalities revisited. Soc Sci Med 2006, 62(3):694-706.
18. Mhatre S.L., Schryer-Roy A.-M. The fallacy of coverage: uncovering disparities to improve immunization rates through evidence. Results from the Canadian International Immunization Initiative Phase 2 - operational research grants. BMC Int Health Hum Rights 2009, 9(Suppl. 1):S1.
19. Pande R.P., Yazbeck A.S. What's in a country average? Wealth, gender, and regional inequalities in immunization in India. Soc Sci Med 2003, 57(11):2075-2088.
20. Singh P.K. Trends in child immunization across geographical regions in India: focus on urban-rural and gender differentials. PLOS ONE 2013, 8(9):e73102.
21. Corsi D.J., Bassani D.G., Kumar R., Awasthi S., Jotkar R., Kaur N., et al. Gender inequity and age-appropriate immunization coverage in India from 1992 to 2006. BMC Int Health Hum Rights 2009, 9(Suppl. 1):S3.
22. Microsoft Microsoft excel 2011, Redmond, Washington.
23. Rutstein S.O., Johnson K. The DHS wealth index 2004, ORC Macro, Calverton, Maryland.
24. International Institute for Population Sciences Macro international. National family health survey (NFHS-3), 2005-06 2007, vol. I. IIPS, Mumbai.
25. StataCorp Stata statistical software: release 12 2011, StataCorp LP, College Station, TX.
26. Munos M.K., Walker C.L.F., Black R.E. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol 2010, 39:75-87.
27. Murray C., Lopez A. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, School of Public Health, Harvard University, Boston, MA.
28. Prüss-Üstün A., et al. Introduction and methods: assessing the environmental burden of disease at national and local levels 2003, World Health Organization, Geneva, (WHO Environmental Burden of Disease Series, No. 1).
29. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200 (Suppl. 1):S9-S15.
30. Rheingans R.D., Constenla D., Antil L., Innis B.L., Breuer T. Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries. Rev Panam Salud Pública 2007, 21(4):192-204.
31. Sanderson C., Clark A., Taylor D., Bolanos B. Global review of rotavirus morbidity and mortality data by age and region. WHO SAGE Meeting 2012, 1-42.
32. Clark A., Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009, 373(9674):1543-1549.
33. International Institute for Population Sciences (IIPS) District level household and facility survey (DLHS-3), 2007-08 2010, IIPS, Mumbai, India.
34. UNICEF 2009 coverage evaluation survey: all India report 2010, UNICEF, New Delhi.
35. Vital Statistics Division Annual health survey 1010-11 fact sheet: Uttar Pradesh 2011, Office of the Registrar General and Census Commissioner, New Delhi, India.
36. Vital Statistics Division Annual health survey 1010-11 fact sheet: Bihar 2011, Office of the Registrar General and Census Commissioner, New Delhi, India.
37. Vital Statistics Division Annual health survey 1010-11 fact sheet: Madhya Pradesh 2011, Office of the Registrar General and Census Commissioner, New Delhi, India.
38. Rheingans R.D., Antil L., Dreibelbis R., Podewils L.J., Bresee J.S., Parashar U.D. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009, 200(Suppl. 1):S16-S27.
39. Lopman B.A., Pitzer V.E., Sarkar R., Gladstone B., Patel M., Glasser J., et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 2012, 7(8):e41720.
40. Sowmyanarayanan T.V., Patel T., Sarkar R., Broor S., Chitambar S.D., Krishnan T., et al. Direct costs of hospitalization for rotavirus gastroenteritis in different health facilities in India. Indian J Med Res 2012, 136(1):68-73.
41. Tate J.E., Chitambar S., Esposito D.H., Sarkar R., Gladstone B., Ramani S., et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine 2009, 27:F18-F24.
42. Rheingans R., Kukla M., Faruque A.S., Sur D., Zaidi A.K., Nasrin D., et al. Determinants of household costs associated with childhood diarrhea in 3 South Asian settings. Clin Infect Dis 2012, 55(Suppl. 4(Dec)):S327-S335.
43. Decisioneering Inc. Crystal ball version 11.0 2007, Oracle, Denver, CO.
44. The World Bank Gross domestic product per capita (current US$). World development indicators 2012 [cited April 2014] 2014, Available from:. http://data.worldbank.org/indicator/NY.GDP.PCAP.CD/countries.
45. Victora C.G., Vaughan J.P., Barros F.C., Silva A.C., Tomasi E. Explaining trends in inequities: evidence from Brazilian child health studies. Lancet 2000, 356(9235(Sep)):1093-1098.
46. Verguet S., Murphy S., Anderson B., Johansson K.A. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine 2013, 31(42):4902-4910.
47. Fischer Walker C., Black R. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health 2011, 11(Suppl. 3):S16.